Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 08, 2019

SELL
$1.28 - $2.24 $1,610 - $2,817
-1,258 Closed
0 $0
Q3 2018

Nov 02, 2018

BUY
$1.23 - $1.49 $1,547 - $1,874
1,258 New
1,258 $2,000
Q2 2018

Aug 13, 2018

SELL
$0.85 - $1.5 $1,069 - $1,887
-1,258 Closed
0 $0
Q1 2018

May 10, 2018

BUY
$0.91 - $1.73 $1,144 - $2,176
1,258 New
1,258 $1,000

Others Institutions Holding VTGN

About VistaGen Therapeutics, Inc.


  • Ticker VTGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 206,836,000
  • Market Cap $730M
  • Description
  • VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...
More about VTGN
Track This Portfolio

Track Stratos Wealth Partners, Ltd. Portfolio

Follow Stratos Wealth Partners, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.